Scarica l'app Stockscreener
3.62
1.90%
-0.07
Dopo l'orario di chiusura:
3.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.69
Aprire:
$3.84
Volume 24 ore:
346.12K
Relative Volume:
0.85
Capitalizzazione di mercato:
$111.06M
Reddito:
$875.70K
Utile/perdita netta:
$-39.57M
Rapporto P/E:
-2.6969
EPS:
-1.3423
Flusso di cassa netto:
$-33.65M
1 W Prestazione:
+12.07%
1M Prestazione:
+24.40%
6M Prestazione:
+36.60%
1 anno Prestazione:
+11.04%
Intervallo 1D:
$3.59
$3.88
Intervallo di 1 settimana:
$3.1399
$3.88
Portata 52W:
$1.90
$3.88
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
Nome
Vistagen Therapeutics Inc
Settore
Industria
Telefono
650-577-3600
Indirizzo
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Confronta VTGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
3.62 | 108.00M | 875.70K | -39.57M | -33.65M | -1.3423 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-07 | Aggiornamento | Maxim Group | Hold → Buy |
| 2022-07-22 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | Iniziato | Robert W. Baird | Outperform |
| 2021-02-18 | Iniziato | Jefferies | Buy |
| 2021-01-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | Iniziato | Maxim Group | Buy |
| 2018-02-08 | Reiterato | Chardan Capital Markets | Buy |
| 2017-03-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
Measuring Vistagen Therapeutics Inc.’s beta against major indicesWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser
Is Vistagen Therapeutics Inc. forming a bullish divergenceJobs Report & Capital Efficient Trade Techniques - khodrobank.com
Tick level data insight on Vistagen Therapeutics Inc. volatilityCEO Change & Free High Return Stock Watch Alerts - Newser
Is this a good reentry point in Vistagen Therapeutics Inc.Market Sentiment Summary & Stepwise Entry/Exit Trade Alerts - Newser
Real time social sentiment graph for Vistagen Therapeutics Inc.Quarterly Market Summary & Community Consensus Trade Alerts - Newser
Can Vistagen Therapeutics Inc. rally from current levels2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Is Vistagen Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser
How to monitor Vistagen Therapeutics Inc. with trend dashboardsWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser
Why is Vistagen Therapeutics Inc. stock going down2025 Growth vs Value & Accurate Buy Signal Notifications - khodrobank.com
What to do if you’re stuck in Vistagen Therapeutics Inc.Earnings Overview Report & Safe Entry Momentum Stock Tips - Newser
Earnings visualization tools for Vistagen Therapeutics Inc.Entry Point & High Accuracy Swing Trade Signals - Newser
Is Vistagen Therapeutics Inc.’s growth already priced inJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - khodrobank.com
Using flow based indicators on Vistagen Therapeutics Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Vistagen Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Review & Low Risk High Win Rate Stock Picks - Newser
VistaGen Bets On Nasal Therapies For Anxiety And Depression - Finimize
Published on: 2025-09-02 16:30:46 - khodrobank.com
Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial - Yahoo Finance
Price momentum metrics for Vistagen Therapeutics Inc. explainedGap Down & Fast Moving Stock Watchlists - Newser
Is Vistagen Therapeutics Inc. a top pick in the sectorJuly 2025 Drop Watch & Smart Investment Allocation Insights - khodrobank.com
Is Vistagen Therapeutics Inc. stock undervalued right nowJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - khodrobank.com
Is this a good reentry point in Vistagen Therapeutics Inc2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-08-31 23:17:23 - Newser
Short interest data insights for Vistagen Therapeutics Inc.2025 Winners & Losers & AI Driven Stock Reports - Newser
Using AI based signals to follow Vistagen Therapeutics Inc.Trade Risk Report & Safe Entry Point Identification - Newser
Vistagen Therapeutics Inc. stock chart pattern explainedJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - Newser
Vistagen Therapeutics Inc. stock outlook for YEARWeekly Trading Summary & Expert Verified Movement Alerts - Newser
What candlestick patterns are forming on Vistagen Therapeutics Inc.July 2025 Sentiment & Free Reliable Trade Execution Plans - Newser
Will Vistagen Therapeutics Inc. Benefit From Sector Tailwinds getLinesFromResByArray error: size == 0 - 더경남뉴스
Published on: 2025-08-30 22:37:47 - Newser
Why Vistagen Therapeutics Inc. stock attracts strong analyst attentionEarnings Summary Report & Stepwise Trade Signal Implementation - Newser
Volatility clustering patterns for Vistagen Therapeutics Inc.Global Markets & Fast Gain Stock Tips - Newser
Pattern recognition hints at Vistagen Therapeutics Inc. upsideJuly 2025 Earnings & Technical Buy Zone Confirmations - Newser
Vistagen Therapeutics Inc Azioni (VTGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):